Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease

By Fischer M.   Carlone G.M.   Holst J.   Williams D.   Stephens D.S.   Perkins B.A.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2377-2383

Elsevier

Access to resources Recommend Favorite

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

By Claassen I.   Meylis J.   van der Ley P.   Peeters C.   Brons H.   Robert J.   Borsboom D.   van der Ark A.   van Straaten I.   Roholl P.   Kuipers B.   Poolman J.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 1001-1008

Elsevier

Access to resources Recommend Favorite

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

By van der Ley P.   van der Biezen J.   Poolman J.T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins

By Cartwright K.   Morris R.   Rumke H.   Fox A.   Ray Borrow   Begg N.   Richmond P.   Poolman J.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2612-2619

Elsevier

Access to resources Recommend Favorite

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

By Holst J.   Feiring B.   Fuglesang J.E.   Hoiby E.A.   Nokleby H.   Aaberge I.S.   Rosenqvist E.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 734-737

Elsevier

Access to resources Recommend Favorite